Peptidyl-methionine modification

pathway activity — cross-omics
GO:0018206Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-methionine modification pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are PTPRC, SH3BP1, and VEZF1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-methionine modification activity versus PTPRC in GBM (Pearson r = 0.16).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMPTPRC →-0.560-0.054<.001<.00137
GBMSH3BP1 →-0.284-0.060<.001<.00137
GBMVEZF1 →+0.411+0.074.002<.00137
CCRCCCYBB →-0.592-0.051.001<.00137
HNSCISG20 →-0.549-0.061<.001.00137
GBMPARVG →-0.526-0.061<.001<.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018206 vs PTPRC — GBM

Per-sample scatter of Peptidyl-methionine modification activity vs PTPRC in GBM.

Explore this scatter interactively →

Exploration